| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |